The Pharmacy Times® COVID Treatment Resource Center is a comprehensive resource for clinical news and expert insights on the treatment of patients infected with SARS-CoV-2.
March 27th 2023
Pharmacists on duty decline to dispense the medication to manage COVID-19, raising question about self-determination.
Post-COVID-19 Symptoms Not Worse Among Hospitalized Patients Compared to Non-hospitalized PatientsNovember 21st 2022
Approximately 2 years after patients were infected with COVID-19, non-hospitalized patients suffered from post-COVID-19 symptoms nearly 8% more than hospitalized patients.
Study: Significant New Onset Morbidity Observed in Children, Adolescents, Adults Following COVID-19 InfectionNovember 21st 2022
Although long-term health issues from COVID-19 are a major public health concern, evidence on post-acute COVID-19 syndrome, or post-COVID-19, is still limited, specifically among children and adolescents.
Three Strategies for Pharmacists to Maximize Their Potential as Caregivers Beyond the BenchNovember 15th 2022
In recent years, pharmacist roles have evolved as critically important caregivers who increasingly provide essential health care services far beyond medication dispensing.
Expert: Long-term Care Industry Needs Help of Pharmacists to Improve Infection Prevention, ControlNovember 7th 2022
A session presenter at the ASCP 2022 Annual Meeting explained how the COVID-19 pandemic significantly magnified the importance of infection prevention and control practices in long-term care.
Risk of Developing Severe Breakthrough Infection From COVID-19 May Increase Over 50 Years of AgeOctober 21st 2022
The risk of severe COVID-19 breakthrough infection was stronger with age and some comorbidities—the findings can inform antiviral distribution to prevent death or respiratory failure.
Study Finds Lack of Honesty About Following COVID-19 Public Health Measures During the PandemicOctober 18th 2022
Many people wanted life to feel normal during the COVID-19 pandemic; however, this reason, among many, resulted in people not adhering to public health measures in the United States.
The PREP Act Declaration and How the COVID-19 Pandemic Changed the Perception and Role of Pharmacy TechniciansOctober 17th 2022
Because we need to be prepared and respond to future crises, making these changes permanent is a top priority for the profession of pharmacy.
COVID-19 Infection Increases Risk of Diabetes Diagnosis in Pediatric PatientsOctober 14th 2022
At month 6 post-COVID-19 infection, 123 patients received a diagnosis of type 1 diabetes (T1D) and only 72 were diagnosed with T1D at 6 months post-non-COVID-19 respiratory infection.
Study Results Show Link Between Excess Weight and Risk of COVID-19, Lasting DiseaseSeptember 23rd 2022
Analyses of more than 30,000 adults in the United Kingdom from 9 prospective cohort studies finds a high pre-pandemic BMI was associated with the infection.
Low Testosterone in Men May be a Risk Factor for Hospitalization from COVID-19September 16th 2022
Men with chronically low testosterone levels are more likely to be hospitalized from COVID-19 than those with normal levels, but testosterone therapy could decrease this risk.
Study: Myocarditis Risk Is Significantly Higher After COVID-19 Infection Vs After VaccineAugust 24th 2022
Analysis includes nearly 43 million individuals aged 13 year and older who received at least 1 dose in England between December 1, 2020, and December 15, 2021.
Lack of Awareness of Omicron Variant Infectious Status in More than Half of Adults Contributes to High Transmission RatesAugust 22nd 2022
Overall low awareness of the Omicron variant infection contributed to high transmission rates and rapid spread of SARS-CoV-2 in communities.
Trial Results Suggest Metformin Is Effective at Reducing Odds of Serious COVID-19 OutcomesAugust 22nd 2022
University of Minnesota Medical School Analysis shows comparison with fluvoxamine and ivermectin in a double-blinded, placebo-controlled, randomized study.